Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an update.
Wai Chun Bio-Technology Ltd. delayed the publication of its annual results for the fiscal year ending June 30, 2024, due to significant changes in key accounting personnel and the appointment of new auditors unfamiliar with the company’s financial reporting processes. As a result, the company did not publish unaudited management accounts to avoid potential confusion among shareholders and investors. The company is actively taking remedial actions, including recruiting new financial staff and revising financial reporting procedures, to ensure timely compliance with listing rules and prevent similar issues in the future.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, engaged in the biotechnology industry. It operates with a focus on providing innovative solutions within its market sector.
YTD Price Performance: 20.0%
Average Trading Volume: 111,240
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$14.4M
For an in-depth examination of 0660 stock, go to TipRanks’ Stock Analysis page.
